Ananda Pharma Confirms Safety of CBD Drug, as Clinical Pain Trials Approach
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. CBDSafetyPainResearchPolicyAnxietyMental Health Why This Matters As CBD-based pharmaceuticals advance through clinical…
Curaleaf International Launches CPD-Accredited Education Platform for UK Cannabis Prescribers
UK clinicians now have access to a CPD accredited cannabis education platform that fills critical gaps in medical cannabis prescribing knowledge. This education supports evidence-based practice for patient selection and dosing. The platform aims to…
Cannabis loyalty isn’t built on high-potency THC – it’s built on trust
✦ New CED Clinical Relevance #77 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. DosingTHCCBDSafetyIndustryResearchPolicy Why This Matters Clinicians should understand that patient cannabis use…
France Sets July Deadline for Medical Cannabis Regulations, as Study Shows Opioid Reductions
✦ New CED Clinical Relevance #77 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PolicyResearchPainNeurologyMental HealthSafetyDosing Why This Matters Clinicians treating patients with chronic pain…
CED Cannabis Science Digest: 3 Surgery, Pregnancy, and Pain Signals Worth Watching
Three additional cannabis science signals on surgery outcomes, prenatal safety messaging, and early pain-delivery research, preserved with clear evidence limits.
Cannabis Science Full Report: What a Phase 2 CBD Autism Trial Found
A 2026 phase 2 open-label cannabidiol autism trial reported early symptom improvement signals with mostly mild adverse events. The study was small and uncontrolled, limiting efficacy conclusions. This trial offers preliminary clinical insights into…
What 26 Studies and 3,598 Patients Reveal About Cannabis and PTSD
This medical cannabis PTSD scoping review examines 26 studies and 3,598 patients. The controlled-trial evidence did not support broad PTSD symptom benefit, with one narrow signal for nabilone and nightmares. The article explains what the review shows,…
CED Cannabis Science Digest: 3 Evidence and Measurement Signals Worth Watching
This digest highlights 3 evidence and measurement signals in cannabis science that help separate clinical proof from preliminary data. It covers systematic reviews, a human HIV biomarker study, and improved cannabinoid measurement methods. These signals…
Tennessee THCA ban: Will drinks and edibles still be legal?
✦ New CED Clinical Relevance #47 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyHempTHCSafetyIndustryAnxietyPain Why This Matters Clinicians in Tennessee need to understand this regulatory shift…
PSNI officer facing ‘performance procedures’ over wrongful seizure of prescribed cannabis
✦ New CED Clinical Relevance #52 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicySafetyCBDTHCHempMental HealthAnxiety Why This Matters Clinicians should be aware that law enforcement may not…